Abstract
Background: Acute rejection reactions and the development of graft arterial disease are serious limitations after transplantation. Both are connected to the expression of adhesion molecules on the activated microvascular endothelium of the allograft. Methods: siRNA-mediated silencing of ESELE, ICAM-1, and VCAM-1 on human cardiac microvascular cells (HCMEC) was investigated in order to inhibit leukocyte-endothelial interactions. HCMEC were investigated for the time-dependent expression of ESELE, ICAM-1, and VCAM-1 after TNF-α stimulation and for siRNA mediated suppression using a nonviral transfecting approach. Furthermore, the effects of siRNA transfection on leukocyte binding to the endothelium were analyzed. Results: Transfection with siRNA induced a significant suppression of adhesion molecule expression, regardless of whether there had been a prior single or cocktail transfection of the sequences (p < 0.05). The quantity of attaching leukocytes was significantly reduced after an equal silencing of adhesion molecules (p < 0.05). Conclusions: This investigation demonstrates that liposomal transfection of HCMEC with specific siRNA sequences is capable of both repressing adhesion molecule expression and of reducing subsequent leukocyte-endothelial actions.
Key words
transplantation - heart - endothelium (includes related subject matter) - ischemia/reperfusion
References
-
1
Daneshmand M A, Rajagopal K, Lima B et al.
Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
Ann Thorac Surg.
2010;
89
(4)
1205-1209
-
2
Smits J M, Rahmel A, Laufer G et al.
Considerations for patients awaiting heart transplantation.
Thorac Cardiovasc Surg.
2010;
58
S179-S184
-
3
Ardehali A, Laks H, Drinkwater D C et al.
Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
Circulation.
1995;
92
(3)
450-456
-
4
Labarrere C A, Nelson D R, Spear K L.
Non-immunologic vascular failure of the transplanted heart.
J Heart Lung Transplant.
2003;
22
(3)
236-240
-
5
Sadahiro M, McDonald T O, Allen M D.
Reduction in cellular and vascular rejection by blocking leukocyte adhesion molecule receptors.
Am J Pathol.
1993;
142
(3)
675-683
-
6
Briscoe D M, DesRoches L E, Kiely J M et al.
Antigen-dependent activation of T helper cell subsets by endothelium.
Transplantation.
1995;
59
(11)
1638-1641
-
7
Pober J S, Orosz C G, Rose M L et al.
Can graft endothelial cells initiate a host anti-graft immune response?.
Transplantation.
1996;
61
(3)
343-349
-
8
Denton M D, Davis S F, Baum M A et al.
The role of the graft endothelium in transplant rejection: evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection.
Pediatr Transplant.
2000;
4
(4)
252-260
-
9
Tuschl T.
RNA interference and small interfering RNAs.
Chembiochem.
2001;
2
(4)
239-245
-
10
Elbashir S M, Harborth J, Lendeckel W et al.
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.
Nature.
2001;
411
(6836)
494-498
-
11
Yang Z K, Draper N J, Shah A M.
Ca2+-independent inhibition of myocardial contraction by coronary effluent of hypoxic rat hearts.
Am J Physiol.
1999;
276 (2 Pt 2)
H623-H632
-
12
Walker T, Wendel H P, Tetzloff L et al.
Suppression of ICAM-1 in human venous endothelial cells by small interfering RNAs.
Eur J Cardiothorac Surg.
2005;
28
(6)
816-820
-
13
Walker T, Wendel H P, Tetzloff L et al.
Inhibition of adhesion molecule expression on human venous endothelial cells by non-viral siRNA transfection.
J Cell Mol Med.
2007;
11
(1)
139-147
-
14
Walker T, Wendel H P, Raabe C et al.
Graft protection in bypass surgery: siRNA-mediated silencing of adhesion molecules.
Oligonucleotides.
2009;
19
(1)
15-21
-
15
Rozen S, Skaletsky H.
Primer3 on the WWW for general users and for biologist programmers.
Methods Mol Biol.
2000;
132
365-386
-
16
Simon P, Feldkaemper M, Bitzer M et al.
Early transcriptional changes of retinal and choroidal TGFbeta-2, RALDH-2, and ZENK following imposed positive and negative defocus in chickens.
Mol Vis.
2004;
10
588-597
-
17
Suzuki J, Isobe M, Morishita R et al.
Characteristics of chronic rejection in heart transplantation: important elements of pathogenesis and future treatments.
Circ J.
2010;
74
(2)
233-239
-
18
Jordan J E, Zhao Z Q, Vinten-Johansen J.
The role of neutrophils in myocardial ischemia-reperfusion injury.
Cardiovasc Res.
1999;
43
(4)
860-878
-
19
Shuhaiber J H, Evans A N, Massad M G et al.
Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery.
Eur J Cardiothorac Surg.
2002;
22
(3)
387-396
-
20
Tanio J W, Basu C B, Albelda S M et al.
Differential expression of the cell adhesion molecules ICAM-1, VCAM-1, and E-selectin in normal and posttransplantation myocardium. Cell adhesion molecule expression in human cardiac allografts.
Circulation.
1994;
89
(4)
1760-1768
-
21
Labarrere C A, Nelson D R, Faulk W P.
Endothelial activation and development of coronary artery disease in transplanted human hearts.
JAMA.
1997;
278
(14)
1169-1175
-
22
Dykxhoorn D M, Palliser D, Lieberman J.
The silent treatment: siRNAs as small molecule drugs.
Gene Ther.
2006;
13
(6)
541-552
-
23
Sibley C R, Seow Y, Wood M J.
Novel RNA-based strategies for therapeutic gene silencing.
Mol Ther.
2010;
18
(3)
466-476
Dr. Tobias Walker
Clinic for Thoracic, Cardiac and Vascular Surgery
University of Tübingen
Hoppe-Seyler-Straße 3
72076 Tübingen
Germany
Phone: +49 7 07 12 98 32 88
Fax: +49 70 71 29 53 69
Email: tobias.walker@med.uni-tuebingen.de
